Adverse external ocular effects of topical ophthalmic medications.
about
Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs.Neomycin, polymyxin B, and dexamethasone allergic reactions following periocular surgery.Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998)Sjögren's syndrome: current therapies remain inadequate for a common disease.Dry eye disease.Tear analysis in contact lens wearersAdverse external ocular effects of topical ophthalmic therapy: an epidemiologic, laboratory, and clinical study.Changes in ocular surface caused by antiglaucomatous eyedrops: prospective, randomised study for the comparison of 0.5% timolol v 0. 12% unoprostonePrevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.Corneal toxicity: the epithelium and stroma in iatrogenic and factitious disease.Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease.Ocular allergy. Scratching the surface of the red eye.Equine keratomycoses in California from 1987 to 2010 (47 cases).Pseudodentritic keratitis associated with meibomitis in young healthy males.Self-medication: initial treatments used by patients seen in an ophthalmologic emergency room.Pilot study on the effect of topical adrenergic medications on human Tenon's capsule fibroblasts in tissue culture.Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study.Dry eye syndrome (DES) and watering eyes.Current practice pattern for dry eye patients in South Korea: a multicenter study.Chloramphenicol 4. Responsible topical use in ophthalmology.Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK).Practice patterns and opinions in the treatment of acanthamoeba keratitis.Ophthalmology-epitomes of progress: danger with eyedrops.Adverse effects of topical antiglaucomatous medications on the conjunctiva.Chronic progressive conjunctival cicatrisation.Changes in corneal parameters at confocal microscopy in treated glaucoma patients.Severe generalised hypersensitivity reaction to topical neomycin after cataract surgery: a case report.Comparison of the ocular comfort of ofloxacin 0.3% ophthalmic solution and lubricant eye drops.Effects of anti-inflammatory drugs and preservatives on morphologic characteristics and migration of canine corneal epithelial cells in tissue culture.Cytotoxicity evaluation of soft contact lens care solutions on human conjunctival fibroblasts.Keratomycosis in a pet rabbit (Oryctolagus cuniculus) treated with topical 1% terbinafine ointment.Follicular conjunctivitis on Dipivefrin therapy for glaucoma.
P2860
Q28345266-5C7BF814-78C2-462E-926A-59B112C6F354Q33789220-A57A494B-61D1-4F43-A2CF-294C1D42BD88Q33979791-4186B7D0-2FCA-49DF-8D73-6321CE73AD02Q34075047-17CEAE73-D518-4C50-9893-D477AB24EB80Q34123349-4B79E4DA-DC96-4A70-B62B-0755892302F7Q34164909-0CF45F02-4730-4766-936E-ABD56C3DED04Q34213079-B371F4B8-BFF4-450B-9B10-05E07F4CF207Q35312605-8991098C-D088-440E-9F63-EA0B0ED49569Q35589561-3741E50A-330A-4D66-9FE1-29D0A265E1C9Q35590386-FD7A54ED-16F2-4C00-A24A-E18B5D58C56EQ35592019-D4F1E75A-837F-4A7B-9144-248703BA3FD5Q36430317-3D74A62E-AF9D-4765-A50D-E1AA6E188155Q36448962-D6E1B56E-16F3-4A9A-9203-77E51F58CE50Q36551450-5C946C07-1561-411D-B825-FC1763BA340AQ37308628-9A6490B1-50CE-4657-B9A4-82628DEA4295Q37310121-815C2BDE-A90A-47ED-A704-2BAB5ACCCF24Q37318205-97C5A7D7-8AC3-4D8D-ABF0-5A9B86064DD7Q37341595-BC318F70-CA52-4D49-820D-81B4901F1CCAQ37644776-9E6195F3-AC59-4257-8C57-8327D28BC68EQ37698664-2832112C-1FEE-4542-AD0E-BE1979EB00BAQ38843414-6EE9F8AB-6317-46BC-B75E-F3AAD27C771FQ39215509-987CF265-E5CB-43C9-89A7-DC753085BDF6Q39363450-EBEABBC6-3F2A-4C87-BCDC-CE9E5392702CQ39936116-5A9FF832-C0AF-403F-B22C-68F6EABDAF8BQ40773560-4A7A8AD5-C248-4D83-BE37-2F45C585508DQ42075931-D8D84B29-D325-4A76-A57B-CB107452EC8FQ43076195-4F6D7361-7A30-49F2-A1E8-CA650115E915Q43985790-F5E7D9C8-92A1-4325-B6CA-EDD15B54D8E7Q44033047-CF03A7FB-4123-4813-A663-4EC7797A53BEQ45163321-346C4458-8D7B-458B-BEC5-4DCAF0D772F6Q47960039-F1D8A77A-714F-4EF9-B421-E1AC670E77D6Q54129329-083309F2-BBDE-4823-B410-B1D657E6F9CE
P2860
Adverse external ocular effects of topical ophthalmic medications.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Adverse external ocular effects of topical ophthalmic medications.
@en
Adverse external ocular effects of topical ophthalmic medications.
@nl
type
label
Adverse external ocular effects of topical ophthalmic medications.
@en
Adverse external ocular effects of topical ophthalmic medications.
@nl
prefLabel
Adverse external ocular effects of topical ophthalmic medications.
@en
Adverse external ocular effects of topical ophthalmic medications.
@nl
P1476
Adverse external ocular effects of topical ophthalmic medications.
@en
P2093
Wilson FM 2nd
P356
10.1016/0039-6257(79)90125-5
P577
1979-09-01T00:00:00Z